These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28166667)

  • 21. Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.
    Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
    J Clin Pathol; 2006 Aug; 59(8):867-9. PubMed ID: 16644878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease.
    Williams AO
    Br J Exp Pathol; 1965 Oct; 46(5):564-8. PubMed ID: 5838405
    [No Abstract]   [Full Text] [Related]  

  • 23. An inductively coupled plasma mass spectrometry method for relative free copper determination and generation of a paediatric reference interval.
    Wainwright P; Wadey D; Cook P
    Ann Clin Biochem; 2018 Jul; 55(4):485-490. PubMed ID: 29153026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups.
    Gibbs K; Walshe JM
    Q J Med; 1979 Jul; 48(191):447-63. PubMed ID: 396544
    [No Abstract]   [Full Text] [Related]  

  • 27. Calculated parameters for the diagnosis of Wilson disease.
    Zulkufli NS; Sthaneshwar P; Chan WK
    Singapore Med J; 2023 Mar; 64(3):188-195. PubMed ID: 35139628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The heterogeneity of caeruloplasmin nd the enzymatic defect in Wilson's disease.
    RICHTERICH R; GAUTIER E; STILLHART H; ROSSI E
    Helv Paediatr Acta; 1960 Nov; 15():424-36. PubMed ID: 13741432
    [No Abstract]   [Full Text] [Related]  

  • 29. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure.
    Sallie R; Katsiyiannakis L; Baldwin D; Davies S; O'Grady J; Mowat A; Mieli-Vergani G; Williams R
    Hepatology; 1992 Nov; 16(5):1206-11. PubMed ID: 1427659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of ceruloplasmin in the differential diagnosis of neuropsychiatric disorders].
    Connemann BJ; Schönfeldt-Lecuona C; Maxon HJ; Kratzer W; Kassubek J
    Fortschr Neurol Psychiatr; 2010 Oct; 78(10):582-9. PubMed ID: 20812166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilson's disease and the concentration of caeruloplasmin in serum.
    SCHEINBERG IH; STERNLIEB I
    Lancet; 1963 Jun; 1(7296):1420-1. PubMed ID: 13991539
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of superoxide dismutase, diamine oxidase and caeruloplasmin oxidase in the blood of thoroughbreds.
    Smith P; Stubley D; Blackmore DJ
    Res Vet Sci; 1983 Sep; 35(2):160-4. PubMed ID: 6415770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilson's disease: a patient undiagnosed for 18 years.
    Mak CM; Tam S; Fan ST; Liu CL; Lam CW
    Hong Kong Med J; 2006 Apr; 12(2):154-8. PubMed ID: 16603785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assay in serum of exchangeable copper and total copper using inductively coupled plasma mass spectrometry (ICP-MS): development, optimisation and evaluation of a routine procedure.
    Daymond R; Curtis SL; Mishra V; Roberts NB
    Scand J Clin Lab Invest; 2020 Dec; 80(8):630-639. PubMed ID: 32955383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated assay of ceruloplasmin by kinetic analysis of o-dianisidine oxidation.
    Boyett JD; Lehmann HP; Beeler MF
    Clin Chim Acta; 1976 Jun; 69(2):233-41. PubMed ID: 1277556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of histaminase (diamine oxidase) activity by o-dianisidine test: interference of ceruloplasmin.
    Biegański T; Blasinska MZ; Kusche J
    Agents Actions; 1977 Mar; 7(1):85-92. PubMed ID: 404858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assessment of efficiency in potential screening for Wilson's disease.
    Saito T
    J Epidemiol Community Health; 1981 Dec; 35(4):274-80. PubMed ID: 7338703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caeruloplasmin in Wilson's disease.
    ROSENOER VM; FRANGLEN G
    Lancet; 1959 Dec; 2(7113):1163-4. PubMed ID: 14439030
    [No Abstract]   [Full Text] [Related]  

  • 40. The fate of 99Mo-labelled sodium tetrathiomolybdate after duodenal administration in sheep: the effect on caeruloplasmin (EC 1.16.3.1) diamine oxidase activity and plasma copper.
    Mason J; Lamand M; Kelleher CA
    Br J Nutr; 1980 May; 43(3):515-23. PubMed ID: 6774744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.